Difference between revisions of "Part:BBa K2610035"
JazzyDeWaard (Talk | contribs) |
|||
(3 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K2610035 short</partinfo> | <partinfo>BBa_K2610035 short</partinfo> | ||
− | This composite part features twice the regulatory part promoter SoxS (BBa_K2610030) and two times the | + | This composite part features twice the regulatory part promoter SoxS ([https://parts.igem.org/Part:BBa_K2610030 BBa_K2610030]) and two times the fluorescent protein GFP ([https://parts.igem.org/Part:BBa_E0040 BBa_E0040]). It can be used to visualize upregulation of SoxS as a result of superoxide stress. |
− | Regulatory protein SoxS is involved in the | + | Regulatory protein SoxS is involved in the oxidative stress signaling pathway in <i> Escherichia coli </i>. Intracellular superoxide-generating compounds cause the SoxR to activate transcription of SoxS, which then triggers a set of defense and repair genes that form the oxidative response system. |
===Usage and Biology=== | ===Usage and Biology=== | ||
− | |||
− | + | We, iGEM Leiden 2018, have designed this composite part as part of our project Fifty Shades of Stress. This reporter part allowed us to detect stress-induced changes in SoxS transcription. We have created this part in order to amplify the fluorescent signal measured after pSoxS-GFP activation. | |
− | [ | + | As can be observed in Figure 1 the pSoxS-GFP-pSoxS-GFP construct leads to an increased mean fluorescence intensity compared to pSoxS-GFP ([https://parts.igem.org/Part:BBa_K2610031 BBa_K2610031]), but not compared to pSoXS-GFP-pSoxS-GFP ([https://parts.igem.org/Part:BBa_K2610034 BBa_K2610034]). |
− | <span style="font-size:1em"><b>Figure 1.</b> | + | We also assessed the dose-dependency of this reporter. We found that an increase in nalidixic acid concentration of nalidixic acid leads to an increasing mean fluorescence intensity (MFI). A decrease in detected GFP expression at higher concentrations can be attributed to the lethality of the stressor. |
+ | |||
+ | [[File:T--Leiden--amplificA.png|200px]] [[File:T--Leiden--amplificB.jpeg|200px]] [[File:T--Leiden--amplficC.jpeg|200px]]<br><br> | ||
+ | <span style="font-size:1em"><b>Figure 1.</b> Median fluorescence intensity (MFI) as a result of treatment with nalidixic acid for pSoxS-GFP-GFP-pSoxS-GFP-GFP compared to pSoxS-GFP-pSoxS-GFP and pSoxS-GFP . It can also be seen that there is a dose response curve to nalidixic acid. The decrease in detected GFP expression at higher concentrations can be attributed to lethality of the stressor. </span> | ||
Latest revision as of 02:22, 18 October 2018
pSoxS-GFP-GFP-pSoxS-GFP-GFP
This composite part features twice the regulatory part promoter SoxS (BBa_K2610030) and two times the fluorescent protein GFP (BBa_E0040). It can be used to visualize upregulation of SoxS as a result of superoxide stress.
Regulatory protein SoxS is involved in the oxidative stress signaling pathway in Escherichia coli . Intracellular superoxide-generating compounds cause the SoxR to activate transcription of SoxS, which then triggers a set of defense and repair genes that form the oxidative response system.
Usage and Biology
We, iGEM Leiden 2018, have designed this composite part as part of our project Fifty Shades of Stress. This reporter part allowed us to detect stress-induced changes in SoxS transcription. We have created this part in order to amplify the fluorescent signal measured after pSoxS-GFP activation.
As can be observed in Figure 1 the pSoxS-GFP-pSoxS-GFP construct leads to an increased mean fluorescence intensity compared to pSoxS-GFP (BBa_K2610031), but not compared to pSoXS-GFP-pSoxS-GFP (BBa_K2610034).
We also assessed the dose-dependency of this reporter. We found that an increase in nalidixic acid concentration of nalidixic acid leads to an increasing mean fluorescence intensity (MFI). A decrease in detected GFP expression at higher concentrations can be attributed to the lethality of the stressor.
Figure 1. Median fluorescence intensity (MFI) as a result of treatment with nalidixic acid for pSoxS-GFP-GFP-pSoxS-GFP-GFP compared to pSoxS-GFP-pSoxS-GFP and pSoxS-GFP . It can also be seen that there is a dose response curve to nalidixic acid. The decrease in detected GFP expression at higher concentrations can be attributed to lethality of the stressor.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 947
Illegal BsaI.rc site found at 1673
Illegal BsaI.rc site found at 2704
Illegal BsaI.rc site found at 3430